1887

Journal of Medical Microbiology logo

Volume 73, Issue 4

Gut microbiota plays a significant role in gout No Access

Abstract

With the development of social economy, the incidence of gout is increasing, which is closely related to people’s increasingly rich diet. Eating a diet high in purine, fat, sugar and low-fibre for a long time further aggravates gout by affecting uric acid metabolism. The renal metabolism mechanism of uric acid has been thoroughly studied. To find a new treatment method for gout, increasing studies have recently been conducted on the mechanism of intestinal excretion, metabolism and absorption of uric acid. The most important research is the relationship between intestinal microbiota and the risk of gout. Gut microbiota represent bacteria that reside in a host’s gastrointestinal tract. The composition of the gut microbiota is associated with protection against pathogen colonization and disease occurrence. This review focuses on how gut microbiota affects gout through uric acid and discusses the types of bacteria that may be involved in the occurrence and progression of gout. We also describe potential therapy for gout by restoring gut microbiota homeostasis and reducing uric acid levels. We hold the perspective that changing intestinal microbiota may become a vital method for effectively preventing or treating gout.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): gout , gut microbiota , novel therapy and uric acid
Funding
This study was supported by the:
  • The key laboratory of human genetic diseases research of Inner Mongolia, China（NO. YC202201)；Basic research funding of Guangdong province, China (NO. 2023A1515010798)
  • Zhanjiang city science and technology development special fund competitive allocation project (NO. 2020A01037)
© 2024 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001824
2024-04-17
2024-04-30
Loading full text...

Full text loading...

References

  1. Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol 2016; 213:8–14 [View Article] [PubMed]
     [Google Scholar]
  2. Krishnan E, Akhras KS, Sharma H, Marynchenko M, Wu E et al. Serum urate and incidence of kidney disease among veterans with gout. J Rheumatol 2013; 40:1166–1172 [View Article]
     [Google Scholar]
  3. Kondratiuk VE, Tarasenko OM, Karmazina OM, Taranchuk VV. Impact of the synbiotics and urate-lowering therapy on gut microbiota and cytokine profile in patients with chronic gouty arthritis. J Med Life 2020; 13:490–498 [View Article] [PubMed]
     [Google Scholar]
  4. El Ridi R, Tallima H. Physiological functions and pathogenic potential of uric acid: a review. J Adv Res 2017; 8:487–493 [View Article] [PubMed]
     [Google Scholar]
  5. Shi Y, Li J, Yang P, Niu Z, Wei L et al. Colchicine increases intestinal permeability, suppresses inflammatory responses, and alters gut microbiota in mice. Toxicol Lett 2020; 334:66–77 [View Article] [PubMed]
     [Google Scholar]
  6. Sorensen LB. Role of the intestinal tract in the elimination of uric acid. Arthritis Rheum 1965; 8:694–706 [View Article] [PubMed]
     [Google Scholar]
  7. Fan P, Tingting Y, Yue W. The research progress of uric acid metabolism in Intestine[J]. J Med Postgra 2015; 28:763–766 [View Article]
     [Google Scholar]
  8. Feng Z-P, Xin H-Y, Zhang Z-W, Liu C-G, Yang Z et al. Gut microbiota homeostasis restoration may become a novel therapy for breast cancer. Invest New Drugs 2021; 39:871–878 [View Article] [PubMed]
     [Google Scholar]
  9. Cao T, Li X, Mao T et al. Probiotic therapy alleviates hyperuricemia in C57Bl/6 mouse model[J]. Biomed Res 2017; 28:2244–2249
     [Google Scholar]
  10. Liu X, Lv Q, Ren H, Gao L, Zhao P et al. The altered gut microbiota of high-purine-induced hyperuricemia rats and its correlation with hyperuricemia. PeerJ 2020; 8:e8664 [View Article] [PubMed]
     [Google Scholar]
  11. Beyl RN, Hughes L, Morgan S. Update on importance of diet in gout. Am J Med 2016; 129:1153–1158 [View Article] [PubMed]
     [Google Scholar]
  12. Mutlu EA, Gillevet PM, Rangwala H, Sikaroodi M, Naqvi A et al. Colonic microbiome is altered in alcoholism. Am J Physiol Gastrointest Liver Physiol 2012; 302:G966–78 [View Article] [PubMed]
     [Google Scholar]
  13. Yan AW, Fouts DE, Brandl J, Stärkel P, Torralba M et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 2011; 53:96–105 [View Article] [PubMed]
     [Google Scholar]
  14. Xi Y, Huang Y, Li Y, Yan J, Shi Z. Fermented feed supplement relieves caecal microbiota dysbiosis and kidney injury caused by high-protein diet in the development of gosling gout. Animals 2020; 10:2139 [View Article]
     [Google Scholar]
  15. Kanbay M, Solak Y, Dogan E, Lanaspa MA, Covic A. Uric acid in hypertension and renal disease: the chicken or the egg. Blood Purif 2010; 30:288–295 [View Article]
     [Google Scholar]
  16. Yerlikaya A, Dagel T, King C, Kuwabara M, Lanaspa MA et al. Dietary and commercialized fructose: sweet or sour?. Int Urol Nephrol 2017; 49:1611–1620 [View Article] [PubMed]
     [Google Scholar]
  17. Do MH, Lee E, Oh M-J, Kim Y, Park H-Y. High-glucose or -fructose diet cause changes of the gut microbiota and metabolic disorders in mice without body weight change. Nutrients 2018; 10:761 [View Article] [PubMed]
     [Google Scholar]
  18. Büsing F, Hägele FA, Nas A, Döbert L-V, Fricker A et al. High intake of orange juice and cola differently affects metabolic risk in healthy subjects. Clin Nutr 2019; 38:812–819 [View Article] [PubMed]
     [Google Scholar]
  19. Lin X, Shao T, Wen X, Wang M, Wen C et al. Combined effects of MSU crystals injection and high fat-diet feeding on the establishment of a gout model in C57BL/6 mice. Adv Rheumatol 2020; 60:52 [View Article] [PubMed]
     [Google Scholar]
  20. Vieira AT, Galvão I, Macia LM, Sernaglia ÉM, Vinolo MAR et al. Dietary fiber and the short-chain fatty acid acetate promote resolution of neutrophilic inflammation in a model of gout in mice. J Leukoc Biol 2017; 101:275–284 [View Article] [PubMed]
     [Google Scholar]
  21. Guo Z, Zhang J, Wang Z, Ang KY, Huang S et al. Intestinal microbiota distinguish gout patients from healthy humans. Sci Rep 2016; 6:20602 [View Article] [PubMed]
     [Google Scholar]
  22. Yamada N, Iwamoto C, Kano H, Yamaoka N, Fukuuchi T et al. Evaluation of purine utilization by Lactobacillus gasseri strains with potential to decrease the absorption of food-derived purines in the human intestine. Nucleos Nucleot Nucl Acid 2016; 35:670–676 [View Article] [PubMed]
     [Google Scholar]
  23. Crane JK. Role of host xanthine oxidase in infection due to enteropathogenic and Shiga-toxigenic Escherichia coli. Gut Microbes 2013; 4:388–391 [View Article] [PubMed]
     [Google Scholar]
  24. Yu Y, Liu Q, Li H, Wen C, He Z. Alterations of the gut microbiome associated with the treatment of hyperuricaemia in male rats. Front Microbiol 2018; 9:2233 [View Article] [PubMed]
     [Google Scholar]
  25. Tiejuan S, Li S, Haichang L et al. Combined signature of the fecal microbiome and metabolome in patients with Gout[J]. Front Microbiol 2017; 2015:707–715 [View Article]
     [Google Scholar]
  26. Xing S-C, Meng D-M, Chen Y, Jiang G, Liu X-S et al. Study on the diversity of bacteroides and clostridium in patients with primary gout. Cell Biochem Biophys 2015; 71:707–715 [View Article] [PubMed]
     [Google Scholar]
  27. Xu D, Lv Q, Wang X, Cui X, Zhao P et al. Hyperuricemia is associated with impaired intestinal permeability in mice. Am J Physiol Gastrointest Liver Physiol 2019; 317:G484–G492 [View Article]
     [Google Scholar]
  28. Ren K, Yong C. Analysis of intestinal Flora in patients with hyperuricemia in Qindao district. J Chin Phys 2014; 16:1649–1651
     [Google Scholar]
  29. Lv Q, Xu D, Zhang X, Yang X, Zhao P et al. Association of hyperuricemia with immune disorders and intestinal barrier dysfunction. Front Physiol 2020; 11:524236 [View Article] [PubMed]
     [Google Scholar]
  30. Xi Y, Yan J, Li M, Ying S, Shi Z. Gut microbiota dysbiosis increases the risk of visceral gout in goslings through translocation of gut-derived lipopolysaccharide. Poult Sci 2019; 98:5361–5373 [View Article] [PubMed]
     [Google Scholar]
  31. Chiaro TR, Soto R, Zac Stephens W, Kubinak JL, Petersen C et al. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. Sci Transl Med 2017; 9:eaaf9044 [View Article] [PubMed]
     [Google Scholar]
  32. Pan L, Han P, Ma S, Peng R, Wang C et al. Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia. Acta Pharm Sin B 2020; 10:249–261 [View Article] [PubMed]
     [Google Scholar]
  33. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57:1470–1481 [View Article] [PubMed]
     [Google Scholar]
  34. Liu X-X, Sun S-W, Yuan W-J, Gao H, Si Y-Y et al. Isolation of tricin as a xanthine oxidase inhibitor from sweet white clover (Melilotus albus) and its distribution in selected Gramineae Species. Molecules 2018; 23:2719 [View Article] [PubMed]
     [Google Scholar]
  35. Cleophas MCP, Crişan TO, Lemmers H, Toenhake-Dijkstra H, Fossati G et al. Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases. Ann Rheum Dis 2016; 75:593–600 [View Article] [PubMed]
     [Google Scholar]
  36. Guo Y, Yu Y, Li H, Ding X, Li X et al. Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout mice. Eur J Nutr 2021; 60:2217–2230 [View Article] [PubMed]
     [Google Scholar]
  37. Shang H, Sun J, Chen YQ. Clostridium butyricum CGMCC0313.1 modulates lipid profile, insulin resistance and colon homeostasis in obese mice. PLoS One 2016; 11:e0154373 [View Article] [PubMed]
     [Google Scholar]
  38. Yang J-Y, Kweon M-N. The gut microbiota: a key regulator of metabolic diseases. BMB Rep 2016; 49:536–541 [View Article] [PubMed]
     [Google Scholar]
  39. Wrigley R, Phipps-Green AJ, Topless RK, Major TJ, Cadzow M et al. Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout. Arthritis Res Ther 2020; 22:45 [View Article] [PubMed]
     [Google Scholar]
  40. Matsuo H, Takada T, Ichida K, Nakamura T, Nakayama A et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med 2009; 1:5ra11 [View Article] [PubMed]
     [Google Scholar]
  41. Ichida K, Matsuo H, Takada T, Nakayama A, Murakami K et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun 2012; 3:764 [View Article] [PubMed]
     [Google Scholar]
  42. Yano H, Tamura Y, Kobayashi K, Tanemoto M, Uchida S. Uric acid transporter ABCG2 is increased in the intestine of the 5/6 nephrectomy rat model of chronic kidney disease. Clin Exp Nephrol 2014; 18:50–55 [View Article] [PubMed]
     [Google Scholar]
  43. DeBosch BJ, Kluth O, Fujiwara H, Schürmann A, Moley K. Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9. Nat Commun 2014; 5:4642 [View Article] [PubMed]
     [Google Scholar]
  44. Shang H, Sun J, Chen YQ. Clostridium butyricum CGMCC0313.1 modulates lipid profile, insulin resistance and colon homeostasis in obese mice. PLoS One 2016; 11:e0154373 [View Article] [PubMed]
     [Google Scholar]
  45. Li W, Zhirong F, Yating S. Effects of Clostridium butyricum on serum uric acid and inflammatory mediators in rats with hyperuricemia. J South Med Univ 2017; 37:678–682
     [Google Scholar]
  46. Xiao YX, Zhang CX, Zeng XL. Analysis of therapeutic effects of probiotics on renal injury induced by hyperuricemia. Chin General Practice 2020; 23:1376–1382
     [Google Scholar]
  47. Hirosi T, Noriko K, Akina S. Lactic Acid Bacteria Having Action of Lowering Blood Uric Acid Level US8460918B2:
     [Google Scholar]
  48. Hirosi T, Noriko K, Akina S. Lactic Acid Bacterium Having Effect of Lowering Blood Uric Acid Level EP2221360B1:
     [Google Scholar]
  49. Fang J, Hong Y. Isolation of hypouricemic probiotics and exploration their effects on hyperuricemic rats. Microbiol China 2018; 45:1757–1769
     [Google Scholar]
  50. Li M, Yang D, Mei L, Yuan L, Xie A et al. Screening and characterization of purine nucleoside degrading lactic acid bacteria isolated from Chinese sauerkraut and evaluation of the serum uric acid lowering effect in hyperuricemic rats. PLoS One 2014; 9:e105577 [View Article] [PubMed]
     [Google Scholar]
  51. Wang H, Mei L, Deng Y, Liu Y, Wei X et al. Lactobacillus brevis DM9218 ameliorates fructose-induced hyperuricemia through inosine degradation and manipulation of intestinal dysbiosis. Nutrition 2019; 62:63–73 [View Article] [PubMed]
     [Google Scholar]
  52. Chien C-Y, Chien Y-J, Lin Y-H, Lin Y-H, Chan S-T et al. Supplementation of Lactobacillus plantarum (TCI227) prevented potassium-oxonate-induced hyperuricemia in rats. Nutrients 2022; 14:4832 [View Article] [PubMed]
     [Google Scholar]
  53. Yamanaka H, Taniguchi A, Tsuboi H, Kano H, Asami Y. Hypouricaemic effects of yoghurt containing Lactobacillus gasseri PA-3 in patients with hyperuricaemia and/or gout: a randomised, double-blind, placebo-controlled study. Mod Rheumatol 2019; 29:146–150 [View Article] [PubMed]
     [Google Scholar]
  54. Jumeil M, Weirui Z, Sheng H. Isolation of a lactic acid bacterium with high ability of purine nucleoside-decomposing and evaluation of its probiotic properties. J Food Sci Biotechnol 2019; 38:8–14
     [Google Scholar]
  55. Kumemura M, Ikenaga T. Composition for Lowering Serum Uric Acid Level EP1649863A1:
     [Google Scholar]
  56. Cao J, Wang T, Liu Y, Zhou W, Hao H et al. Lactobacillus fermentum F40-4 ameliorates hyperuricemia by modulating the gut microbiota and alleviating inflammation in mice. Food Funct 2023; 14:3259–3268 [View Article] [PubMed]
     [Google Scholar]
  57. Chun-hua N, Ru-xue X, Zi-jian Z. Serum uric acid lowering effect of Lactobacillus plantarum Ua149 on hyperuricemic rats. Modern Food Sci Technol 2020; 36:1–6
     [Google Scholar]
  58. Shi R, Ye J, Fan H, Xiao C, Wang D et al. Lactobacillus plantarum LLY-606 supplementation ameliorates hyperuricemia via modulating intestinal homeostasis and relieving inflammation. Food Funct 2023; 14:5663–5677 [View Article]
     [Google Scholar]
  59. Cao J, Liu Q, Hao H, Bu Y, Tian X et al. Lactobacillus paracasei X11 ameliorates hyperuricemia and modulates gut microbiota in mice. Front Immunol 2022; 13:940228 [View Article] [PubMed]
     [Google Scholar]
  60. Lixia T, Jie L, Xianjun L. Construction and Secetory expression of gene engineering bacteria of uric acid enzyme. J Chongqing Med Univ 2018; 43:127–130
     [Google Scholar]
  61. Wu Y, Ye Z, Feng P, Li R, Chen X et al. Limosilactobacillus fermentum JL-3 isolated from “Jiangshui” ameliorates hyperuricemia by degrading uric acid. Gut Microbes 2021; 13:1–18 [View Article] [PubMed]
     [Google Scholar]
  62. Wan H, Han J, Tang S, Bao W, Lu C et al. Comparisons of protective effects between two sea cucumber hydrolysates against diet induced hyperuricemia and renal inflammation in mice. Food Funct 2020; 11:1074–1086 [View Article] [PubMed]
     [Google Scholar]
  63. Lin X, Shao T, Huang L, Wen X, Wang M et al. Simiao decoction alleviates gouty arthritis by modulating proinflammatory cytokines and the gut ecosystem. Front Pharmacol 2020; 11:955 [View Article] [PubMed]
     [Google Scholar]
  64. Hongpo W, Bing Z, Zhijia L. Effect of Chicory extracts on gut Flora of Hypertriglyceride in hyperuricemia rat model. Inform Trad Chin Med 2015; 32:4–8
     [Google Scholar]
  65. Zhu F, Lou Z. Effects of Folium Mori on serum uric acid levels and gut microbiota in rats with hyperuricemia. Chin J Mod Appl Pharm 2017; 34:1084–1088
     [Google Scholar]
  66. Wang L-M, Wang P, Teka T, Zhang Y-C, Yang W-Z et al. 1H NMR and UHPLC/Q-orbitrap-MS-based metabolomics combined with 16S rRNA gut microbiota analysis revealed the potential regulation mechanism of nuciferine in hyperuricemia rats. J Agric Food Chem 2020; 68:14059–14070 [View Article] [PubMed]
     [Google Scholar]
  67. Xu Y, Cao X, Zhao H, Yang E, Wang Y et al. Impact of Camellia japonica bee pollen polyphenols on hyperuricemia and gut microbiota in potassium oxonate-induced mice. Nutrients 2021; 13:2665 [View Article] [PubMed]
     [Google Scholar]
  68. Wen X, Lou Y, Song S, He Z, Chen J et al. Qu-Zhuo-Tong-Bi decoction alleviates gouty arthritis by regulating butyrate-producing bacteria in mice. Front Pharmacol 2020; 11:610556 [View Article] [PubMed]
     [Google Scholar]
  69. Wang Y, Zhang S, Borody TJ, Zhang F. Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases. Chin Med J 2022; 135:1927–1939 [View Article] [PubMed]
     [Google Scholar]
  70. Xie W-R, Yang X-Y, Deng Z-H, Zheng Y-M, Zhang R et al. Effects of washed microbiota transplantation on serum uric acid levels, symptoms, and intestinal barrier function in patients with acute and recurrent gout: a pilot study. Dig Dis 2022; 40:684–690 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001824
Loading
Gut microbiota plays a significant role in gout
J. Med. Microbiol. 73, 001824 (2024); https://doi.org/10.1099/jmm.0.001824
/content/journal/jmm/10.1099/jmm.0.001824
/content/journal/jmm/10.1099/jmm.0.001824
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error